If you have been reading about purity certificate and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Last reviewed on 2026-06-05. Where a claim depends on a specific study, the study is described rather than over-claimed.
The designation TB-500 circulates in laboratory and catalog contexts without a single agreed definition. Most product listings apply it to an N-terminally acetylated seven-residue fragment of thymosin beta-4, while other listings attach the same label to the full 43-residue protein. Because the term is commercial rather than systematic, two entries bearing identical names may describe different molecules. Any documentation should therefore state which sequence a given sample is claimed to contain.
The fragment most often associated with the name carries the sequence Ac-LKKTETQ, matching residues 17 through 23 of thymosin beta-4. That region holds the actin-binding motif responsible for much of the parent protein's biochemical activity. Apart from N-terminal acetylation the peptide is unmodified and contains no disulfide bonds, so it shows little ordered secondary structure in solution. Full-length thymosin beta-4 is instead a 43-residue polypeptide of roughly 4.9 kDa found widely across mammalian cell types.
Material sold under this label typically arrives as a freeze-dried powder in a sealed vial with a certificate of analysis. Such certificates usually report reversed-phase chromatography purity plus a mass confirmation, and stated purities commonly sit between 95 and 99 percent. Counter-ion identity, residual trifluoroacetate, water content, and peptide net weight are separate specifications that a certificate may or may not include. A purity figure alone does not establish sequence identity, so independent mass verification remains the practical check.
TB-500 is a research peptide whose sequence matches residues 17 to 23 of thymosin beta-4, a 43-residue protein present in most mammalian cells. The chain is seven amino acids long, written as LKKTETQ, and is normally supplied with an acetyl group on the N-terminus. Suppliers list it as a lyophilised powder under the code name TB-500, and the same sequence appears elsewhere in catalogues as the thymosin beta-4 actin-binding fragment. The label is commercial rather than systematic, so no single authority fixes exactly what TB-500 denotes.
Thymosin beta-4 was isolated from calf thymus in the early 1980s and later characterised as an abundant intracellular actin-sequestering protein. Interest in short synthetic fragments grew once the actin-binding motif had been mapped to the middle of the sequence. TB-500 came out of that line of work as a truncated analogue rather than a natural isolate, and it is now sold mainly to laboratories. Published studies on the fragment have been largely in vitro or in animal models, and controlled human trials remain sparse, so claims about effects in people rest on extrapolation.
Literature and online discussion often conflate TB-500 with full-length thymosin beta-4, even though the two differ in size and are not interchangeable in analytical terms. The fragment is produced by solid-phase peptide synthesis, and the product is a defined seven-residue chain rather than a biological extract. Because the term is a trade-style label, two vendors may supply materials of the same nominal sequence but different counter-ion content, purity, or water content. Comparisons across studies are therefore difficult unless the exact sequence and purity are reported.
| Property | Value | Notes |
|---|---|---|
| Molecular mass | ≈889 Da for the 7-residue fragment | Full-length thymosin beta-4 is ≈4.9 kDa; catalogs differ |
| Appearance | White to off-white powder | Hygroscopic; weight shifts with residual moisture |
| Solubility class | Freely soluble in water | Also dissolves in aqueous buffers; poorly soluble in nonpolar solvents |
| Typical storage temperature | −20 °C, desiccated, protected from light | Once rehydrated, short-term holding at 2-8 °C |
| Typical analytical method | Reversed-phase HPLC with mass spectrometry | Purity by UV absorbance; identity by ESI-MS or MALDI-TOF |
Once dissolved, the peptide is far less stable than the dry powder. Aqueous solutions are subject to hydrolysis, oxidation at susceptible residues and gradual loss of material through adsorption onto glass and plastic surfaces. Terminal glutamine can cyclise under some conditions, producing a related species that complicates purity assessment. Dilute solutions tend to lose a larger fraction of material to surfaces than concentrated ones. Buffers, pH and ionic strength all influence the rate of change, so stability figures are only meaningful when those parameters are stated alongside the storage interval.
Detection in biological samples relies on mass spectrometry, typically liquid chromatography coupled to tandem mass spectrometry after peptide extraction and enrichment. Intact peptides can also be confirmed by high-resolution mass measurement together with fragmentation data. Detection windows in urine are short because the peptide is degraded by proteases and cleared quickly, and concentrations are low. Many jurisdictions treat the compound as a prohibited substance in sport, grouped with peptide hormones and related factors, while it is not an approved therapeutic product. Identity and purity statements therefore rest on certificates of analysis, ideally issued by an independent laboratory.
Biological interest in this peptide centers on its relationship to actin dynamics. Thymosin beta-4 binds monomeric actin through an LKKTET motif, and a short sequence carrying that motif can compete with other actin-binding proteins in cell-free preparations. Investigators propose that such competition shifts the balance between filament assembly and disassembly, which in turn affects how readily a cell extends protrusions and migrates. Most of the supporting observations come from cultured cells and purified protein systems rather than from intact organisms.
Animal work has examined the peptide in models of cardiac injury, skin wounding, and corneal repair, with reported outcomes covering cell migration, inflammatory cell influx, and tissue remodeling. Several of those experiments used the full-length protein or longer fragments instead of the seven-residue sequence, which makes direct comparison between reports difficult. Results are generally described as tissue-dependent, and effect sizes vary considerably across laboratories. Independent replication is uneven, so the overall picture is incomplete rather than settled.
Controlled human trials of the short fragment are scarce. Much of what appears in review articles is extrapolated from animal models or from studies of the parent protein, and literature searches return a larger body of cardiac and ophthalmic work on thymosin beta-4 than on the abbreviated peptide. Regulatory treatment differs by jurisdiction, and in several countries the material is handled as a research chemical rather than an approved therapeutic. Statements about human benefit should be read as provisional.
Aya Majzoub, Amnesty International's Deputy Regional Director for the Middle East and North Africa, described the attack as a violation of international law that needed to be investigated as a war crime, and that it "seriously endangered the lives of civilians, many of whom were hospitalized and displaced, and whose homes and cars caught fire". Lebanese state media reported that Dhayra and other areas along the western section of the border came under "continuous" bombardment overnight. In the early morning it was reported that multiple people were suffering from symptoms of suffocation after the IDF allegedly fired white phosphorus shells on the village. Three people were injured after an anti-tank missile from Lebanon landed in the Israeli town of Metula. Hezbollah announced that five of its members were killed on the same day but it was unclear if any had involvement in the border infiltration. On 19 October, the Lebanese Armed Forces said that one person was killed and another injured after a group of seven Iranian journalists were targeted with machine guns by Israel, although Iranian state media denied the claim and said that all its journalists were "alive and healthy". UNIFIL peacekeepers said that one person was killed when civilians were caught in a cross-fire at the border. The Lebanese Army requested assistance by UNIFIL to de-escalate the situation, and Israel was asked to suspend fire to allow the rescue operation to proceed.
The mean lifetime of 238U (or any nuclide) is the half-life divided by ln(2) ≈ 0.693 (or multiplied by 1/ln(2) ≈ 1.443), which is about 2×1017 seconds, so 1 mole of 238U emits 3×106 alpha particles per second, producing the same number of thorium-234 atoms. In a closed system an equilibrium would be reached in which all members except the stable end-product have fixed ratios to one another, but in slowly decreasing amount. The amount of 206Pb will increase accordingly while that of 238U decreases; all steps in the decay chain have this same rate of 3×106 decayed particles per second per mole 238U. While 238U is minimally radioactive, its decay products, thorium-234 and protactinium-234, are beta particle emitters with half-lives of about 20 days and one minute respectively. Protactinium-234 decays to uranium-234, which has a half-life of hundreds of millennia, and this isotope does not reach an equilibrium concentration for a very long time. When the two first isotopes in the decay chain reach their relatively small equilibrium concentrations, a sample of initially pure 238U will emit three times the radiation due to 238U itself, and most of this radiation is beta particles. As already touched upon above, when starting with pure 238U, within a human timescale the equilibrium applies for the first three steps in the decay chain only. Thus, for one mole of 238U, 3×106 times per second one alpha and two beta particles and a gamma ray are produced, together 6.7 MeV, for a rate of 3 μW.
Like other cluster decays, alpha decay is fundamentally a quantum tunneling process. Unlike beta decay, it is governed by the interplay between both the strong nuclear force and the electromagnetic force. Alpha particles have a typical kinetic energy of 5 MeV (or ≈ 0.13% of their total energy, 110 TJ/kg) and have a speed of about 15,000,000 m/s, or 5% of the speed of light. There is surprisingly small variation around this energy, due to the strong dependence of the half-life of this process on the energy produced. Because of their relatively large mass, the electric charge of +2 e and relatively low velocity, alpha particles are very likely to interact with other atoms and lose their energy, and their forward motion can be stopped by a few centimeters of air. Approximately 99% of the helium produced on Earth is the result of the alpha decay of underground deposits of minerals containing uranium or thorium. The helium is brought to the surface as a by-product of natural gas production.
Sources: en.wikipedia.org
Line 14: Since 10 September 2016, the Moscow Central Circle (MCC) renovated railroad (the former Moskovskaya Okruzhnaya Zheleznaya Doroga) has been operated as Line 14 of the Moscow Metro. This cone-shaped railroad opened in 1908 (as a freight-only railway from 1934 until the reopening in 2016). Line 11: Another circular metro line—the Big Circle Line (Bolshaya Koltsevaya Liniya)—opened its first stations in 2018 and the remaining stations in 2023. The Kakhovskaya-Savyolovskaya western half of the line was launched in late 2021. The outermost ring within the city is the Moscow Ring Road—often called the MKAD, an acronym for the Russian Московская Кольцевая Автомобильная Дорога—which forms the city's cultural boundary; it was established during the 1950s. It was built at ground level, rather than being elevated, so it forms a barrier to roads that would otherwise pass beneath it. (Before Moscow's 2012 expansion, the MKAD was considered an approximate city boundary.) Outside Moscow, some roads encompassing the city follow the same circular pattern as within city limits; notable examples are the Betonka roads (highways A107 and A108), originally constructed of concrete pads. To reduce traffic on the MKAD, a new ring road—called CKAD, Centralnaya Koltsevaya Avtomobilnaya Doroga, Central Ring Road—was completed outside the MKAD in 2021.
Antioxidant vitamins are found in vegetables, fruits, eggs, legumes and nuts. Vitamins A, C, and E can be destroyed by long-term storage or prolonged cooking. The effects of cooking and food processing are complex, as these processes can also increase the bioavailability of antioxidants, such as some carotenoids in vegetables. Processed food contains fewer antioxidant vitamins than fresh and uncooked foods, as preparation exposes food to heat and oxygen.
==== MeSH E05.300.530 – injections ==== MeSH E05.300.530.370 – injections, intra-arterial MeSH E05.300.530.380 – injections, intra-articular MeSH E05.300.530.430 – injections, intralesional MeSH E05.300.530.440 – injections, intralymphatic MeSH E05.300.530.460 – injections, intramuscular MeSH E05.300.530.490 – injections, intraperitoneal MeSH E05.300.530.540 – injections, intravenous MeSH E05.300.530.550 – injections, intraventricular MeSH E05.300.530.580 – injections, spinal MeSH E05.300.530.580.300 – injections, epidural MeSH E05.300.530.580.300.145 – blood patch, epidural MeSH E05.300.530.620 – injections, subcutaneous MeSH E05.300.530.620.410 – injections, intradermal MeSH E05.300.530.620.570 – injections, jet MeSH E05.300.530.620.570.100 – biolistics MeSH E05.300.530.690 – microinjections
=== Protein analysis === Protein analysis using microPIXE allow for the determination of the elemental composition of liquid and crystalline proteins. microPIXE can quantify the metal content of protein molecules with a relative accuracy of between 10% and 20%. The advantage of microPIXE is that given a protein of known sequence, the X-ray emission from sulfur can be used as an internal standard to calculate the number of metal atoms per protein monomer. Because only relative concentrations are calculated there are only minimal systematic errors, and the results are totally internally consistent. The relative concentrations of DNA to protein (and metals) can also be measured using the phosphate groups of the bases as an internal calibration.
Sources: en.wikipedia.org
Usually not, though usage overlaps. The label most often refers to a short acetylated fragment of the parent protein, while thymosin beta-4 itself is the full 43-residue molecule. Because suppliers vary, a sequence statement is needed to settle the question for any particular lot.
The name is a commercial label rather than a systematic chemical designation, so different vendors and papers attach it to different sequences. Some treat it as a fragment and others as the whole protein. Comparing two reports therefore requires checking what each one actually analyzed.
Typically it reflects the relative area of the main peak in a reversed-phase chromatogram at a given wavelength. It does not confirm the amino acid sequence, the counter-ion, or the amount of peptide by mass. Identity is normally established by a separate mass measurement.
No. Thymosin beta-4 is a 43-residue protein, while TB-500 matches only residues 17 to 23 of that chain. The two are related but differ in size, and a method that identifies one does not automatically identify the other.